Nerve Growth Factor Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working, DelveInsight | Dompé farmaceutici S.p.A., Pfizer Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Merck KGaA, Sanofi, Promega Corporation, and

Nerve Growth Factor emerging therapies are expected to boost the Nerve Growth Factor Market in the upcoming years.

DelveInsight has launched a new report on "Nerve Growth Factor - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Nerve Growth Factor, historical and forecasted epidemiology as well as the Nerve Growth Factor market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Request for a detailed report @ https://www.delveinsight.com/report-store/nerve-growth-factor-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Recent advancements in the Nerve Growth Factor Market:
In October 2023, the FDA granted Fast Track designation to NVG-291, a therapeutic peptide targeting nervous system repair mechanisms, for treating individuals with spinal cord injuries. This designation aims to expedite the development and review process for drugs addressing serious conditions with unmet medical needs.

Some of the key facts of the Nerve Growth Factor Market Report:

Zhao et al. (2022) reported that osteoarthritis (OA) is the third leading cause of disability, affecting around 350 million people globally. Nerve growth factor (NGF) plays a role in pain signal transmission and nociceptor receptor gene expression, acting as a nociceptor sensitizer. It has been explored as a potential target for OA pain treatment. The study found that the risk of rapidly progressive OA at the final follow-up ranged from 0.7% to 6.3% with anti-NGF monoclonal antibody treatment, compared to 0.2% to 1.2% with the active comparator (overall 4.4% vs. 0.8%).
Key Nerve Growth Factor companies such as Dompé farmaceutici S.p.A., Pfizer Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Merck KGaA, Sanofi, Promega Corporation, and Alomone Labs, and others are evaluating new drugs for Nerve Growth Factor to improve the treatment landscape.
Key benefits of the Nerve Growth Factor market report:
Nerve Growth Factor market report covers a descriptive overview and comprehensive insight of the Nerve Growth Factor Epidemiology and Nerve Growth Factor market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Nerve Growth Factor market report provides insights on the current and emerging therapies.
Nerve Growth Factor market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Nerve Growth Factor market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Nerve Growth Factor market.

Got queries? Click here to know more about the Nerve Growth Factor Market Landscape https://www.delveinsight.com/sample-request/nerve-growth-factor-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Nerve Growth Factor Overview

Nerve Growth Factor (NGF), a neurotrophin, plays a crucial role in the nervous, immune, and endocrine systems. It was the first neurotrophin discovered and is essential for neural development, differentiation, and maintenance in both the peripheral (PNS) and central nervous systems (CNS), throughout life. NGF is a pleiotropic factor, produced and utilized by various cell types, including structural and immune cells.

NGF exerts its biological effects through two receptors: the high-affinity trkANGFR, which has tyrosine kinase activity, and the low-affinity p75NTR, a pan-neurotrophin receptor. While trkANGFR promotes survival and growth, p75NTR can activate apoptotic pathways when trkANGFR expression is low. The balance between these receptors determines NGF's impact on target cells.

Reduced NGF transport can lead to nerve damage, as seen in peripheral neuropathies. NGF and its receptors are also linked to tumor cell proliferation, differentiation, and migration in cancers. Additionally, NGF is a key mediator of peripheral pain.

Nerve Growth Factor Market Outlook

The dynamics of the Nerve Growth Factor market is anticipated to change in the coming years owing to the expected launch of emerging therapies by key companies such as Dompé farmaceutici S.p.A., Pfizer Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Merck KGaA, Sanofi, Promega Corporation, and Alomone Labs, and others during the forecast period 2020-2034.

Discover how the nerve growth factor market is rising in the upcoming years @ https://www.delveinsight.com/report-store/nerve-growth-factor-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Nerve Growth Factor Key Companies
Dompé farmaceutici S.p.A., Pfizer Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Merck KGaA, Sanofi, Promega Corporation, and Alomone Labs, and others.

Scope of the Nerve Growth Factor Market Report

Study Period: 2020-2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Nerve Growth Factor Companies: Dompé farmaceutici S.p.A., Pfizer Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Merck KGaA, Sanofi, Promega Corporation, and Alomone Labs, and others
Nerve Growth Factor Therapeutic Assessment: Nerve Growth Factor current marketed and Nerve Growth Factor emerging therapies
Nerve Growth Factor Market Dynamics: Nerve Growth Factor market drivers and Nerve Growth Factor market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Nerve Growth Factor Unmet Needs, KOL's views, Analyst's views, Nerve Growth Factor Market Access and Reimbursement

Request for our free sample pages @ https://www.delveinsight.com/sample-request/nerve-growth-factor-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of Contents

1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Nerve Growth Factor Patient Share (%) Overview at a Glance
5. Nerve Growth Factor Market Overview at a Glance
6. Nerve Growth Factor Disease Background and Overview
7. Nerve Growth Factor Epidemiology and Patient Population
8. Country-Specific Patient Population of Nerve Growth Factor
9. Nerve Growth Factor Current Treatment and Medical Practices
10. Unmet Needs
11. Nerve Growth Factor Emerging Therapies
12. Nerve Growth Factor Market Outlook
13. Country-Wise Nerve Growth Factor Market Analysis (2020-2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Nerve Growth Factor Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Click here to read more about Nerve Growth Factor Market Outlook 2034 https://www.delveinsight.com/sample-request/nerve-growth-factor-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Related Reports:

Nerve Growth Factor Pipeline Insights, DelveInsight

"Nerve Growth Factor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Nerve Growth Factor market. A detailed picture of the Nerve Growth Factor pipeline landscape is provided, which includes the disease overview and Nerve Growth Factor treatment guidelines.

Contact Info:

Kritika Rehani, Team Leader Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.